123 related articles for article (PubMed ID: 32168345)
1. Characterization of the immune cell landscape of patients with NAFLD.
Diedrich T; Kummer S; Galante A; Drolz A; Schlicker V; Lohse AW; Kluwe J; Eberhard JM; Schulze Zur Wiesch J
PLoS One; 2020; 15(3):e0230307. PubMed ID: 32168345
[TBL] [Abstract][Full Text] [Related]
2. Lower NKG2D expression in hepatic natural killer cells predicts poorer prognosis for chronic hepatitis B patients with cirrhosis.
Ma Y; Ping D; Huang K; Tao Y; Peng Y; Sun X; Liu C
Hum Immunol; 2024 May; 85(3):110775. PubMed ID: 38493049
[TBL] [Abstract][Full Text] [Related]
3. Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.
Li Y; Huang B; Jiang X; Chen W; Zhang J; Wei Y; Chen Y; Lian M; Bian Z; Miao Q; Peng Y; Fang J; Wang Q; Tang R; Gershwin ME; Ma X
Front Immunol; 2018; 9():1994. PubMed ID: 30233587
[TBL] [Abstract][Full Text] [Related]
4. Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.
Cairoli V; De Matteo E; Rios D; Lezama C; Galoppo M; Casciato P; Mullen E; Giadans C; Bertot G; Preciado MV; Valva P
Sci Rep; 2021 Mar; 11(1):5129. PubMed ID: 33664397
[TBL] [Abstract][Full Text] [Related]
5. Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells.
Schwane V; Huynh-Tran VH; Vollmers S; Yakup VM; Sauter J; Schmidt AH; Peine S; Altfeld M; Richert L; Körner C
Front Immunol; 2020; 11():568927. PubMed ID: 33335526
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease.
Luo X; Guo J; Deng H; He Z; Wen Y; Si Z; Li J
Front Immunol; 2024; 15():1386905. PubMed ID: 38812509
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance.
Zhou D; Zhao S; He K; Liu Q; Zhang F; Pu Z; Xiao L; Zhang L; Chen S; Qian X; Wu X; Shen Y; Yu L; Zhang H; Jin J; Xu M; Wang X; Zhu D; Xie Z; Xu X
BMC Infect Dis; 2024 Jun; 24(1):567. PubMed ID: 38844850
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells.
Goyal NA; Coulis G; Duarte J; Farahat PK; Mannaa AH; Cauchii J; Irani T; Araujo N; Wang L; Wencel M; Li V; Zhang L; Greenberg SA; Mozaffar T; Villalta SA
Neurology; 2022 Mar; 98(13):e1374-e1383. PubMed ID: 35131904
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis.
Ren A; He W; Rao J; Ye D; Cheng P; Jian Q; Fu Z; Zhang X; Deng R; Gao Y; Ma Y
Front Immunol; 2023; 14():1034356. PubMed ID: 36845083
[TBL] [Abstract][Full Text] [Related]
10. Influence of Immune Cell Subtypes on Mitochondrial Measurements in Peripheral Blood Mononuclear Cells From Children with Sepsis.
Weiss SL; Henrickson SE; Lindell RB; Sartori LF; Zhang D; Bush J; Farooqi S; Starr J; Deutschman CS; McGowan FX; Becker L; Tuluc F; Wherry EJ; Picard M; Wallace DC
Shock; 2022 May; 57(5):630-638. PubMed ID: 34966070
[TBL] [Abstract][Full Text] [Related]
11. Machine learning and experimental validation identified autophagy signature in hepatic fibrosis.
Huang Y; Luo W; Yang Z; Lan T; Wei X; Wu H
Front Immunol; 2024; 15():1337105. PubMed ID: 38481992
[TBL] [Abstract][Full Text] [Related]
12. CD4
Her Z; Tan JHL; Lim YS; Tan SY; Chan XY; Tan WWS; Liu M; Yong KSM; Lai F; Ceccarello E; Zheng Z; Fan Y; Chang KTE; Sun L; Chang SC; Chin CL; Lee GH; Dan YY; Chan YS; Lim SG; Chan JKY; Chandy KG; Chen Q
Front Immunol; 2020; 11():580968. PubMed ID: 33013934
[TBL] [Abstract][Full Text] [Related]
13. Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice.
Heinrich B; Brown ZJ; Diggs LP; Vormehr M; Ma C; Subramanyam V; Rosato U; Ruf B; Walz JS; McVey JC; Wabitsch S; Fu Q; Yu SJ; Zhang Q; Lai CW; Sahin U; Greten TF
Gastroenterology; 2021 Jan; 160(1):331-345.e6. PubMed ID: 33010248
[TBL] [Abstract][Full Text] [Related]
14. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
15. Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis.
Chen Y; Tian Z
Front Immunol; 2020; 11():1500. PubMed ID: 32765518
[TBL] [Abstract][Full Text] [Related]
16. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
Zeng F; Zhang Y; Han X; Zeng M; Gao Y; Weng J
Front Immunol; 2020; 11():609900. PubMed ID: 33574818
[TBL] [Abstract][Full Text] [Related]
17. Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.
Chen Y; Tian Z
Cell Mol Immunol; 2021 Jan; 18(1):57-72. PubMed ID: 33041339
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis.
Gebru YA; Choi MR; Raja G; Gupta H; Sharma SP; Choi YR; Kim HS; Yoon SJ; Kim DJ; Suk KT
Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33535703
[TBL] [Abstract][Full Text] [Related]
19. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
20. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.
Czaja AJ
World J Gastroenterol; 2021 Jul; 27(25):3705-3733. PubMed ID: 34321839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
